: Cardiomyopathies and valvular heart diseases are typically considered distinct diagnostic categories with dedicated guidelines for their management. However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation. Moreover, cardiomyopathies and valvular heart diseases can have a shared aetiology because several genetic or acquired diseases can affect both the cardiac valves and the myocardium. In addition, the association between cardiomyopathies and valvular heart diseases has important prognostic and therapeutic implications. Therefore, a better understanding of their shared pathophysiological mechanisms, as well as of the prevalence and predisposing factors to their association, might lead to a different approach in the risk stratification and management of these diseases. In this Review, we discuss the different scenarios in which valvular heart diseases and cardiomyopathies coexist, highlighting the need for an improved classification and clustering of these diseases with potential repercussions in the clinical management and, particularly, personalized therapeutic approaches.

Ajmone Marsan, N., Graziani, F., Meucci, M. C., Wu, H. W., Lillo, R., Bax, J. J., Burzotta, F., Massetti, M., Wouter Jukema, J., Crea, F., Valvular heart disease and cardiomyopathy: reappraisal of their interplay, <<NATURE REVIEWS. CARDIOLOGY>>, 2023; (Aug 10): N/A-N/A. [doi:10.1038/s41569-023-00911-0] [https://hdl.handle.net/10807/246714]

Valvular heart disease and cardiomyopathy: reappraisal of their interplay

Graziani, Francesca;Lillo, Rosa;Burzotta, Francesco;Massetti, Massimo;Crea, Filippo
2023

Abstract

: Cardiomyopathies and valvular heart diseases are typically considered distinct diagnostic categories with dedicated guidelines for their management. However, the interplay between these conditions is increasingly being recognized and they frequently coexist, as in the paradigmatic examples of dilated cardiomyopathy and hypertrophic cardiomyopathy, which are often complicated by the occurrence of mitral regurgitation. Moreover, cardiomyopathies and valvular heart diseases can have a shared aetiology because several genetic or acquired diseases can affect both the cardiac valves and the myocardium. In addition, the association between cardiomyopathies and valvular heart diseases has important prognostic and therapeutic implications. Therefore, a better understanding of their shared pathophysiological mechanisms, as well as of the prevalence and predisposing factors to their association, might lead to a different approach in the risk stratification and management of these diseases. In this Review, we discuss the different scenarios in which valvular heart diseases and cardiomyopathies coexist, highlighting the need for an improved classification and clustering of these diseases with potential repercussions in the clinical management and, particularly, personalized therapeutic approaches.
2023
Inglese
Ajmone Marsan, N., Graziani, F., Meucci, M. C., Wu, H. W., Lillo, R., Bax, J. J., Burzotta, F., Massetti, M., Wouter Jukema, J., Crea, F., Valvular heart disease and cardiomyopathy: reappraisal of their interplay, <<NATURE REVIEWS. CARDIOLOGY>>, 2023; (Aug 10): N/A-N/A. [doi:10.1038/s41569-023-00911-0] [https://hdl.handle.net/10807/246714]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/246714
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact